BEIJING -- Yaobili is reshaping China's pharmaceutical industry by offering to connect consumers and pharmacies directly on its platform which can only be accessed via WeChat so that drugs can be ordered and delivered more efficiently.
The company has raised tens of millions of yuan, or millions of U.S. dollars, in a series A round from GGV Capital and He Xiaopeng, founder of Xpeng Motors, a manufacturer of electric vehicles.
